Zymeworks Inc (ZYME)
12.57
+0.38
(+3.12%)
USD |
NASDAQ |
Oct 04, 16:00
12.56
-0.01
(-0.08%)
After-Hours: 20:00
Zymeworks Research and Development Expense (TTM): 119.50M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 119.50M |
| March 31, 2024 | 129.75M |
| December 31, 2023 | 143.62M |
| September 30, 2023 | 171.06M |
| June 30, 2023 | 175.38M |
| March 31, 2023 | 192.00M |
| December 31, 2022 | 208.60M |
| September 30, 2022 | 210.49M |
| June 30, 2022 | 223.29M |
| March 31, 2022 | 217.98M |
| December 31, 2021 | 199.75M |
| September 30, 2021 | 184.96M |
| June 30, 2021 | 189.47M |
| March 31, 2021 | 178.54M |
| December 31, 2020 | 171.20M |
| September 30, 2020 | 177.98M |
| Date | Value |
|---|---|
| June 30, 2020 | 152.83M |
| March 31, 2020 | 136.84M |
| December 31, 2019 | 117.37M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | 52.25M |
| March 31, 2018 | 45.17M |
| December 31, 2017 | 41.14M |
| September 30, 2017 | 37.79M |
| June 30, 2017 | 36.02M |
| March 31, 2017 | 37.96M |
| December 31, 2016 | 36.82M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
117.37M
Minimum
Dec 2019
223.29M
Maximum
Jun 2022
173.72M
Average
177.98M
Median
Sep 2020
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 14.91B |
| NovaBay Pharmaceuticals Inc | 0.043M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.61M |